SOLID FORMS OF NILOTINIB HYDROCHLORIDE
A solid form of Nilotinib hydrochloride, which exists as a co-crystal of nilotinib hydrochloride and levulinic acid having a molar ratio of nilotinib hydrochloride to levulinic acid of 1:2, and a process for the preparation of the co-crystal. L'invention concerne une forme solide de chlorhydrat...
Gespeichert in:
| Hauptverfasser: | , , |
|---|---|
| Format: | Patent |
| Sprache: | eng ; fre |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | DATTA, PROBAL KANTI POMPILI, MATTHEW A STRADIOTTO, DAVID A |
| description | A solid form of Nilotinib hydrochloride, which exists as a co-crystal of nilotinib hydrochloride and levulinic acid having a molar ratio of nilotinib hydrochloride to levulinic acid of 1:2, and a process for the preparation of the co-crystal.
L'invention concerne une forme solide de chlorhydrate de nilotinib se présentant sous la forme d'un co-cristal de chlorhydrate de nilotinib et d'acide lévulique, lequel co-cristal a un rapport molaire chlorhydrate de nilotinib/acide lévulinique de 1: 2, et un procédé pour la préparation du co-cristal. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_WO2016058081A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>WO2016058081A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_WO2016058081A13</originalsourceid><addsrcrecordid>eNrjZFAL9vfxdFFw8w_yDVbwd1Pw8_TxD_H083RS8Ih0CfJ39vDxD_J0ceVhYE1LzClO5YXS3AzKbq4hzh66qQX58anFBYnJqXmpJfHh_kYGhmYGphYGFoaOhsbEqQIAV5Ekig</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>SOLID FORMS OF NILOTINIB HYDROCHLORIDE</title><source>esp@cenet</source><creator>DATTA, PROBAL KANTI ; POMPILI, MATTHEW A ; STRADIOTTO, DAVID A</creator><creatorcontrib>DATTA, PROBAL KANTI ; POMPILI, MATTHEW A ; STRADIOTTO, DAVID A</creatorcontrib><description>A solid form of Nilotinib hydrochloride, which exists as a co-crystal of nilotinib hydrochloride and levulinic acid having a molar ratio of nilotinib hydrochloride to levulinic acid of 1:2, and a process for the preparation of the co-crystal.
L'invention concerne une forme solide de chlorhydrate de nilotinib se présentant sous la forme d'un co-cristal de chlorhydrate de nilotinib et d'acide lévulique, lequel co-cristal a un rapport molaire chlorhydrate de nilotinib/acide lévulinique de 1: 2, et un procédé pour la préparation du co-cristal.</description><language>eng ; fre</language><subject>ACYCLIC OR CARBOCYCLIC COMPOUNDS ; CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2016</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20160421&DB=EPODOC&CC=WO&NR=2016058081A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76516</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20160421&DB=EPODOC&CC=WO&NR=2016058081A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>DATTA, PROBAL KANTI</creatorcontrib><creatorcontrib>POMPILI, MATTHEW A</creatorcontrib><creatorcontrib>STRADIOTTO, DAVID A</creatorcontrib><title>SOLID FORMS OF NILOTINIB HYDROCHLORIDE</title><description>A solid form of Nilotinib hydrochloride, which exists as a co-crystal of nilotinib hydrochloride and levulinic acid having a molar ratio of nilotinib hydrochloride to levulinic acid of 1:2, and a process for the preparation of the co-crystal.
L'invention concerne une forme solide de chlorhydrate de nilotinib se présentant sous la forme d'un co-cristal de chlorhydrate de nilotinib et d'acide lévulique, lequel co-cristal a un rapport molaire chlorhydrate de nilotinib/acide lévulinique de 1: 2, et un procédé pour la préparation du co-cristal.</description><subject>ACYCLIC OR CARBOCYCLIC COMPOUNDS</subject><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2016</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZFAL9vfxdFFw8w_yDVbwd1Pw8_TxD_H083RS8Ih0CfJ39vDxD_J0ceVhYE1LzClO5YXS3AzKbq4hzh66qQX58anFBYnJqXmpJfHh_kYGhmYGphYGFoaOhsbEqQIAV5Ekig</recordid><startdate>20160421</startdate><enddate>20160421</enddate><creator>DATTA, PROBAL KANTI</creator><creator>POMPILI, MATTHEW A</creator><creator>STRADIOTTO, DAVID A</creator><scope>EVB</scope></search><sort><creationdate>20160421</creationdate><title>SOLID FORMS OF NILOTINIB HYDROCHLORIDE</title><author>DATTA, PROBAL KANTI ; POMPILI, MATTHEW A ; STRADIOTTO, DAVID A</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_WO2016058081A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre</language><creationdate>2016</creationdate><topic>ACYCLIC OR CARBOCYCLIC COMPOUNDS</topic><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>DATTA, PROBAL KANTI</creatorcontrib><creatorcontrib>POMPILI, MATTHEW A</creatorcontrib><creatorcontrib>STRADIOTTO, DAVID A</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>DATTA, PROBAL KANTI</au><au>POMPILI, MATTHEW A</au><au>STRADIOTTO, DAVID A</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>SOLID FORMS OF NILOTINIB HYDROCHLORIDE</title><date>2016-04-21</date><risdate>2016</risdate><abstract>A solid form of Nilotinib hydrochloride, which exists as a co-crystal of nilotinib hydrochloride and levulinic acid having a molar ratio of nilotinib hydrochloride to levulinic acid of 1:2, and a process for the preparation of the co-crystal.
L'invention concerne une forme solide de chlorhydrate de nilotinib se présentant sous la forme d'un co-cristal de chlorhydrate de nilotinib et d'acide lévulique, lequel co-cristal a un rapport molaire chlorhydrate de nilotinib/acide lévulinique de 1: 2, et un procédé pour la préparation du co-cristal.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng ; fre |
| recordid | cdi_epo_espacenet_WO2016058081A1 |
| source | esp@cenet |
| subjects | ACYCLIC OR CARBOCYCLIC COMPOUNDS CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| title | SOLID FORMS OF NILOTINIB HYDROCHLORIDE |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-15T22%3A10%3A21IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=DATTA,%20PROBAL%20KANTI&rft.date=2016-04-21&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EWO2016058081A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |